Jay L Koyner1, Ryan W Haines2, Josee Bouchard3. 1. Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois, USA. 2. Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, UK. 3. Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
Abstract
PURPOSE OF REVIEW: The aim of this study was to summarize the current evidence around the impact of individualizing patient care following an episode of acute kidney injury (AKI) in the ICU. RECENT FINDINGS: Over the last years, evidence has demonstrated that the follow-up care after episodes of AKI is lacking and standardization of this process is likely needed. Although this is informed largely by large retrospective cohort studies, a few prospective observational trials have been performed. Medication reconciliation and patient/caregiver education are important tenants of follow-up care, regardless of the severity of AKI. There is evidence the initiation and/or reinstitution of renin-angiotensin-aldosterone agents may improve patient's outcomes following AKI, although they may increase the risk for adverse events, especially when reinitiated early. In addition, 3 months after an episode of AKI, serum creatinine and proteinuria evaluation may help identify patients who are likely to develop progressive chronic kidney disease over the ensuing 5 years. Lastly, there are emerging differences between those who do and do not require renal replacement therapy (RRT) for their AKI, which may require more frequent and intense follow-up in those needing RRT. SUMMARY: Although large scale evidence-based guidelines are lacking, standardization of post-ICU-AKI is needed.
PURPOSE OF REVIEW: The aim of this study was to summarize the current evidence around the impact of individualizing patient care following an episode of acute kidney injury (AKI) in the ICU. RECENT FINDINGS: Over the last years, evidence has demonstrated that the follow-up care after episodes of AKI is lacking and standardization of this process is likely needed. Although this is informed largely by large retrospective cohort studies, a few prospective observational trials have been performed. Medication reconciliation and patient/caregiver education are important tenants of follow-up care, regardless of the severity of AKI. There is evidence the initiation and/or reinstitution of renin-angiotensin-aldosterone agents may improve patient's outcomes following AKI, although they may increase the risk for adverse events, especially when reinitiated early. In addition, 3 months after an episode of AKI, serum creatinine and proteinuria evaluation may help identify patients who are likely to develop progressive chronic kidney disease over the ensuing 5 years. Lastly, there are emerging differences between those who do and do not require renal replacement therapy (RRT) for their AKI, which may require more frequent and intense follow-up in those needing RRT. SUMMARY: Although large scale evidence-based guidelines are lacking, standardization of post-ICU-AKI is needed.
Authors: Chi-Yuan Hsu; Vernon M Chinchilli; Steven Coca; Prasad Devarajan; Nasrollah Ghahramani; Alan S Go; Raymond K Hsu; T Alp Ikizler; James Kaufman; Kathleen D Liu; Chirag R Parikh; W Brian Reeves; Mark Wurfel; Michael Zappitelli; Paul L Kimmel; Edward D Siew Journal: JAMA Intern Med Date: 2020-03-01 Impact factor: 21.873
Authors: Nisha Bansal; Michael E Matheny; Robert A Greevy; Svetlana K Eden; Amy M Perkins; Sharidan K Parr; James Fly; Khaled Abdel-Kader; Jonathan Himmelfarb; Adriana M Hung; Theodore Speroff; T Alp Ikizler; Edward D Siew Journal: Am J Kidney Dis Date: 2017-11-20 Impact factor: 8.860
Authors: Matthew T James; Neesh Pannu; Brenda R Hemmelgarn; Peter C Austin; Zhi Tan; Eric McArthur; Braden J Manns; Marcello Tonelli; Ron Wald; Robert R Quinn; Pietro Ravani; Amit X Garg Journal: JAMA Date: 2017-11-14 Impact factor: 56.272
Authors: Ron Wald; Robert R Quinn; Jin Luo; Ping Li; Damon C Scales; Muhammad M Mamdani; Joel G Ray Journal: JAMA Date: 2009-09-16 Impact factor: 56.272
Authors: Charles Hobson; Tezcan Ozrazgat-Baslanti; Adrienne Kuxhausen; Paul Thottakkara; Philip A Efron; Frederick A Moore; Lyle L Moldawer; Mark S Segal; Azra Bihorac Journal: Ann Surg Date: 2015-06 Impact factor: 12.969
Authors: Simon Sawhney; Angharad Marks; Nick Fluck; Adeera Levin; David McLernon; Gordon Prescott; Corri Black Journal: Kidney Int Date: 2017-04-14 Impact factor: 10.612
Authors: L G Forni; M Darmon; M Ostermann; H M Oudemans-van Straaten; V Pettilä; J R Prowle; M Schetz; M Joannidis Journal: Intensive Care Med Date: 2017-05-02 Impact factor: 17.440
Authors: Michael Joannidis; Lui G Forni; Michael Haase; Jay Koyner; Jing Shi; Kianoush Kashani; Lakhmir S Chawla; John A Kellum Journal: Crit Care Med Date: 2019-10 Impact factor: 7.598